To figure out whether these two types of cell death are associated with enhanced anti-tumor immunity induced by HA15 administration, immunofluorescence staining analysis was employed to evaluate the expressions of immunologic death markers Annexin A1, Calreticulin and HMGB1, and necroptotic death marker p-MLKL. The gene discussed is MLKL; the disease is neoplasm.